Showing results (291-300 of 345) with videos related to

Sort By:
Pageof 35
International Journal of Radiation Oncology, Biology, Physics|July 14, 2026
Quality of life results of addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy: NRG Oncology/RTOG 0534 SPPORTDeborah W Bruner, Theodore G Karrison, Alan Pollack, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 4, 2020
American Radium Society Appropriate Use Criteria on Radiation Therapy for Extensive-Stage SCLC, Kristin A Higgins, Charles B Simone, et al.
International Journal of Radiation Oncology, Biology, Physics|January 27, 2019
Gender, Professional Experiences, and Personal Characteristics of Academic Radiation Oncology Chairs: Data to Inform the Pipeline for the 21st CenturyWhitney H Beeler, Kent A Griffith, Rochelle D Jones, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 9, 2020
American Radium Society Appropriate Use Criteria: Radiation Therapy for Limited-Stage SCLC 2020Stephen G Chun, Charles B Simone, Arya Amini, et al.
International Journal of Cancer|September 18, 2008
MicroRNA alterations in head and neck squamous cell carcinomaSteven S Chang, Wei Wen Jiang, Ian Smith, et al.
Brachytherapy|December 15, 2016
ACR appropriateness criteria: Permanent source brachytherapy for prostate cancerBrian J Davis, Al V Taira, Paul L Nguyen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 13, 2024
Appropriate Use Criteria (AUC) for the Management of Non-Small Cell Lung Cancer in a Central/Ultra-Central Location: Guidelines from the American Radium SocietyHenry S Park, Andreas Rimner, Arya Amini, et al.
International Journal of Radiation Oncology, Biology, Physics|September 27, 2021
American Radium Society Appropriate Use Criteria for Radiation Therapy in Oligometastatic or Oligoprogressive Non-Small Cell Lung CancerArya Amini, Vivek Verma, Charles B Simone, et al.
American Journal of Clinical Oncology|March 10, 2022
Uptake of Adjuvant Durvalumab After Definitive Concurrent Chemoradiotherapy for Stage III Nonsmall-cell Lung CancerAlex K Bryant, Huiying Yin, Matthew J Schipper, et al.
Pageof 35